Aulin Sherry
Xenon Pharmaceuticals Inc. · Chief Financial Officer
Aulin Sherry is listed in filings as Chief Financial Officer at Xenon Pharmaceuticals Inc.. This profile follows SEC Form 4 activity through Dec 19, 2024, including sale activity. Recent filings connect the profile to Xenon Pharmaceuticals Inc. (XENE). The current snapshot covers public activity from Dec 19, 2024. Reported amounts are shown as $474.1K to $88.1K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.
Latest Trades
| Company | Value | Action | Price | Last Price |
|---|---|---|---|---|
| $474k11.5k shares | SellDec 18, 2024 | $41.19 | $66.98 | |
| $297k7.2k shares | SellDec 18, 2024 | $41.23 | $66.98 |